Table 1.

Angiosarcoma (AS) survival according to clinical characteristics.

	N (%)	Median (months)	Q1–Q3	Min–Max	Mean (months)	SE	p
All patients	45	10	3–29	0–271	26.2	7.4
Sex							0.55
Men	17 (38)	8	3–30	1–271	31.9	16.1
Women	28 (62)	11	2–25	0–188	22.7	7.0
Age
<50 years	5 (11)	17	7–98	4–271	79.3	51.0	0.005
⩾50 years	45 (89)	9	2–25	0–188	19.5	5.1
<70 years	23 (51)	18	4–44	0–271	41.3	13.7	0.02
⩾70 years	22 (49)	6	1–16	1–47	10.3	2.6
Angiosarcoma types							0.06
Cutaneous and breast AS	23 (55)	18	10–40	0.5–271	39.2	13.3
Visceral AS	19 (45)	4	1–17	0–98	14.4	5.6
Distribution							0.32
Cutaneous AS	12 (29)	18	10–32	1–271	50.9	24.8
Head and neck	6 (14)	18	10–29	10–34	20.0	4.1
Other	6 (14)	15	1–188	0–271	81.9	48.1
Breast AS	11 (26)	18	8–47	3–66	26.3	6.6
Metastasis							0.07
No	31 (74)	16	4–30	1–271	28.5	8.9
Yes	11 (26)	1	0–5	0–44	5.9	3.9
Initial treatment
Surgery	15
Chemotherapy	4
Surgery and radiotherapy	20
Surgery and chemotherapy	3
Chemotherapy and surgery	2
Palliative care	1

Q1: 25%; Q3: 75%; SE: standard error.